EFFECTS OF THE TACHYKININ NK1 RECEPTOR ANTAGONIST, RP-67580, ON CENTRAL CARDIOVASCULAR AND BEHAVIORAL-EFFECTS OF SUBSTANCE-P, NEUROKININ-A AND NEUROKININ-B

被引:26
作者
CULMAN, J [1 ]
WIEGAND, B [1 ]
SPITZNAGEL, H [1 ]
KLEE, S [1 ]
UNGER, T [1 ]
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT PHARMACOL,D-24105 KIEL,GERMANY
关键词
SUBSTANCE P; NEUROKININ A; NEUROKININ B; RP; 67580; BLOOD PRESSURE; HEART RATE; BEHAVIOR; CENTRAL ACTIONS;
D O I
10.1111/j.1476-5381.1995.tb13348.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have investigated the effects of the non-peptide NK1 tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats. 2 The SP and NKA (25 pmol)-induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak. 3 RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP. 4 Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB. 5 Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK1 tachykinin receptors in the rat.
引用
收藏
页码:1310 / 1316
页数:7
相关论文
共 32 条
  • [11] BINDING EPITOPES FOR PEPTIDE AND NONPEPTIDE LIGANDS ON THE NK1 (SUBSTANCE-P) RECEPTOR
    GETHER, U
    JOHANSEN, TE
    SNIDER, RM
    LOWE, JA
    EMONDSALT, X
    YOKOTA, Y
    NAKANISHI, S
    SCHWARTZ, TW
    [J]. REGULATORY PEPTIDES, 1993, 46 (1-2) : 49 - 58
  • [12] INDUCTION OF EXCESSIVE GROOMING IN RAT BY INTRAVENTRICULAR APPLICATION OF PEPTIDES DERIVED FROM ACTH - STRUCTURE-ACTIVITY STUDIES
    GISPEN, WH
    WIEGANT, VM
    GREVEN, HM
    WIED, DD
    [J]. LIFE SCIENCES, 1975, 17 (04) : 645 - 652
  • [13] GRIESBACHER T, 1992, N-S ARCH PHARMACOL, V346, P323
  • [14] THE INTERACTION OF THE NK(1) RECEPTOR ANTAGONIST CP-96,345 WITH L-TYPE CALCIUM CHANNELS AND ITS FUNCTIONAL CONSEQUENCES
    GUARD, S
    BOYLE, SJ
    TANG, KW
    WATLING, KJ
    MCKNIGHT, AT
    WOODRUFF, GN
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) : 385 - 391
  • [15] TACHYKININ RECEPTOR TYPES - CLASSIFICATION AND MEMBRANE SIGNALING MECHANISMS
    GUARD, S
    WATSON, SP
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1991, 18 (02) : 149 - 165
  • [16] DIVERSITY IN MAMMALIAN TACHYKININ PEPTIDERGIC NEURONS - MULTIPLE PEPTIDES, RECEPTORS, AND REGULATORY MECHANISMS
    HELKE, CJ
    KRAUSE, JE
    MANTYH, PW
    COUTURE, R
    BANNON, MJ
    [J]. FASEB JOURNAL, 1990, 4 (06) : 1606 - 1615
  • [17] ITOI K, 1992, EUR J PHARMACOL, V219, P435
  • [18] EFFECT OF RP 67580, A NONPEPTIDE NEUROKININ(1) RECEPTOR ANTAGONIST, ON FACILITATION OF A NOCICEPTIVE SPINAL FLEXION REFLEX IN THE RAT
    LAIRD, JMA
    HARGREAVES, RJ
    HILL, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) : 713 - 718
  • [19] DIFFERENTIAL-EFFECTS OF NONPEPTIDIC TACHYKININ RECEPTOR ANTAGONISTS ON CA2+ CHANNELS
    LOMBET, A
    SPEDDING, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 267 (01): : 113 - 115
  • [20] TACHYKININ RECEPTORS AND TACHYKININ RECEPTOR ANTAGONISTS
    MAGGI, CA
    PATACCHINI, R
    ROVERO, P
    GIACHETTI, A
    [J]. JOURNAL OF AUTONOMIC PHARMACOLOGY, 1993, 13 (01): : 23 - 93